Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
15.29
+1.59 (11.61%)
At close: Jul 16, 2025, 4:00 PM
14.83
-0.46 (-3.01%)
After-hours: Jul 16, 2025, 7:58 PM EDT
RGC Employees
Regencell Bioscience Holdings had 12 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$340,736
Market Cap
7.56B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 12 | 0 | - |
| Jun 30, 2023 | 12 | -1 | -7.69% |
| Jun 30, 2022 | 13 | -1 | -7.14% |
| Jun 30, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RGC News
- 4 weeks ago - This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit - Benzinga
- 4 weeks ago - Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 4 weeks ago - This stock with no revenue surges 64,000% in a year: find out why - Invezz
- 3 years ago - Regencell Bioscience's Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial - Business Wire
- 3 years ago - Slow And Steady Wins The Race With Regencell Bioscience - Seeking Alpha
- 3 years ago - Sector Rotation And 9 Stocks To Watch During A Recession - Benzinga
- 3 years ago - Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period - Business Wire
- 3 years ago - Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO - Business Wire